United Therapeutics Corporation Announces FDA Filing Acceptance of New Drug Application for Ralinepag to Treat Pulmonary Arterial Hypertension
Go back to United Therapeutics Corporation Announces FDA Filing Acceptance of New Drug Application for Ralinepag to Treat Pulmonary Arterial Hypertension| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 487.61 -2.63 (0.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $490.24 | 52 Week High | $164.04 | |||
| Open | $484.33 | 52 Week Low | $97.52 | |||
| Day High | $494.09 | P/E | 89.14 | |||
| Day Low | $484.33 | EPS | $5.47 | |||
| Volume | 327,025 | |||||
